The state of New Mexico urged a judge to hold Walgreens Boots Alliance Inc responsible for fueling the opioid crisis in the state.
Dan Alberstone, a lawyer for New Mexico, told Judge Francis Matthew in the 1st Judicial Circuit of New Mexico in Santa Fe, that the opioid crisis existing in New Mexico was a foreseeable consequence of Walgreens' conduct."
Alberstone accused the company of failing to "maintain effective controls" against the diversion of opioids onto the black market, saying it dispensed suspicious prescriptions without adequate due diligence or documentation.
Steven Derringer, the lawyer arguing for Walgreens, insisted that the opioid crisis was caused by excessive prescriptions and smaller, "mom and pop" pharmacies with lax controls. He added that the state had not offered any evidence that Walgreens dispensed any prescriptions without "legitimate medical purpose."
When the non-jury trial began six weeks ago, it also included claims against Walmart Inc and Kroger Co, but those companies settled with the state last month.


Citigroup Faces Lawsuit Over Alleged Sexual Harassment by Top Wealth Executive
New York Judge Orders Redrawing of GOP-Held Congressional District
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Thailand Inflation Remains Negative for 10th Straight Month in January
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
California Sues Trump Administration Over Federal Authority on Sable Offshore Pipelines
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



